Wednesday, June 26, 2024
News

Chennai doctors successfully perform India's first Robotic Cytoreductive Surgery

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Chennai (Tamil Nadu) | May 9, 2024 11:31:10 PM IST
Surgical oncologists at Chennai's Apollo Cancer Centre (ACC) have successfully performed India's first Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for a peritoneal surface cancer.

This minimally invasive, robotic-assisted approach marks a paradigm shift in treating Pseudomyxoma Peritonei (PMP), an aggressive appendix cancer, offering patients a new standard of care, enabling faster recovery and improved quality of life.

A female patient, aged 51, was diagnosed with bilateral ovarian masses and had extensive surgical intervention, including the removal of the uterus, ovaries, appendix, and part of the omentum, Subsequent histopathological examination revealed a high-grade mucinous tumour of the appendix with pseudomyxoma peritonei (PMP), necessitating additional surgery.

The patient was found to have residual mucinous implants (gelatinous deposits that remain in the abdomen post-surgery for appendicular mucinous tumors) in the pelvis and around the cecum (first part of the colon).

Due to the peculiar tendency of the appendix cancer to spread to the lining of the patient's abdomen (peritoneum), Dr Ajit Pai and team performed minimally invasive Robotic Cytoreductive Surgery (to reduce the amount of cancer cells in the abdominal cavity) with right hemicolectomy (removing the colon which bears the appendix) and complete mesocolic excision (surgery for treating cancer arising from the colon and appendix) and peritonectomy and total omentectomy, along with Hyperthermic intraperitoneal chemotherapy (heated chemotherapy with a chemo drug) eliminating any possible microscopic residual tumours inside the abdomen.

Traditionally, CRS/HIPEC has been performed as an open and extensive operation, with a 10-12-inch incision associated with prolonged hospitalization. The Robotic CRS approach offers significant advantages as it is minimally invasive; the clinicians made use of tiny 8mm incisions for the robotic instruments, minimizing pain, blood loss, scarring and discomfort.

Additionally, a single SCM (sternocleidomastoid) incision was used for tumour removal and the delivery of HIPEC. This novel approach translated to a faster recovery and a quicker return to normal life for the patient. At one year follow-up, she remains in perfect health and cancer-free. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Delhi Excise Case: CBI formally arrests ...
'Better to elect Speaker unanimously, we...
Expect Opposition voice won't be crushed...
'Discussions are going on and it will ha...
Bihar PHED cancels Rs 800 crore tenders ...
'Responsibility of house to fulfil peopl...
More...    
 
 Top Stories
SBI raises Rs 10,000 crore through ... 
"His arrival home ends long-running... 
United Kashmir People's National Pa... 
Geneva: Baloch Voice Association to... 
Kerala assembly passes resolution u... 
Arwachin Schools: Honoured at Indo-... 
How do I choose an overseas educati... 
AM Naik to step down as chairman of...